Kestra Medical officer sells 15,256 shares for taxes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies Chief Business Officer Timothy P. Moran reported nondiscretionary sales of 15,256 common shares to cover tax withholding arising from vested restricted stock units. The shares were sold on July 30, July 31 and August 3, 2026 at weighted average prices of $22.7735, $22.6054 and $23.7611 per share within intraday ranges from $22.15 to $23.98.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares F1, F4 | 2,380 | $23.7611 | $57K |
| Sale | Common Shares F1, F3 | 8,759 | $22.6054 | $198K |
| Sale | Common Shares F1, F2 | 4,117 | $22.7735 | $94K |
Footnotes (4)
- F1. The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- F2. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3800 to $23.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- F3. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1500 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- F4. The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.5800 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Key Figures
Key Terms
restricted stock units financial
sell to cover financial
weighted average price financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were Timothy P. Moran’s KMTS sales executed under a Rule 10b5-1 trading plan?
What position does Timothy P. Moran hold at Kestra Medical Technologies (KMTS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.